id
stringlengths 11
11
| tags
stringlengths 10
777
| text
stringlengths 2
1.5k
| dataset_num
int64 1
3
| tokens
list | ner_tags
list |
|---|---|---|---|---|---|
NCT02553460
|
13:37:treatment
|
one dose of intrathecal chemotherapy
| 1
|
[
"one",
"dose",
"of",
"intrathecal",
"chemotherapy"
] |
[
0,
0,
0,
1,
1
] |
NCT03093909
|
23:26:treatment
|
Subjects who received GCB systemically previously are eligible for participation
| 1
|
[
"Subjects",
"who",
"received",
"GCB",
"systemically",
"previously",
"are",
"eligible",
"for",
"participation"
] |
[
0,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT02592551
|
29:45:cancer,56:76:treatment,110:117:treatment,119:128:treatment,137:152:treatment
|
Symptomatic or uncontrolled brain metastases requiring concurrent treatment, inclusive of but not limited to surgery, radiation, and/or corticosteroids
| 1
|
[
"Symptomatic",
"or",
"uncontrolled",
"brain",
"metastases",
"requiring",
"concurrent",
"treatment",
",",
"inclusive",
"of",
"but",
"not",
"limited",
"to",
"surgery",
",",
"radiation",
",",
"and/or",
"corticosteroids"
] |
[
0,
0,
0,
3,
3,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
0,
1
] |
NCT02624765
|
11:22:chronic_disease
|
Untreated tachycardia at time of enrollment
| 1
|
[
"Untreated",
"tachycardia",
"at",
"time",
"of",
"enrollment"
] |
[
0,
2,
0,
0,
0,
0
] |
NCT00065676
|
1:18:chronic_disease
|
pulmonary disease
| 1
|
[
"pulmonary",
"disease"
] |
[
2,
2
] |
NCT02880215
|
8:47:treatment
|
stable psychiatric and neurological medication usage
| 1
|
[
"stable",
"psychiatric",
"and",
"neurological",
"medication",
"usage"
] |
[
0,
1,
1,
1,
1,
0
] |
NCT00632853
|
44:73:cancer
|
Histologically or cytologically documented small cell lung cancer (SCLC)
| 1
|
[
"Histologically",
"or",
"cytologically",
"documented",
"small",
"cell",
"lung",
"cancer",
"(",
"SCLC",
")"
] |
[
0,
0,
0,
0,
3,
3,
3,
3,
3,
0,
0
] |
NCT02939183
|
72:97:cancer,72:88:cancer,102:132:chronic_disease,,159:166:treatment
|
Subject must have a pathologically documented, definitively diagnosed, multiple myeloma relapsed, or refractory progressive disease after at least 2 lines of therapy for multiple myeloma
| 1
|
[
"Subject",
"must",
"have",
"a",
"pathologically",
"documented",
",",
"definitively",
"diagnosed",
",",
"multiple",
"myeloma",
"relapsed",
",",
"or",
"refractory",
"progressive",
"disease",
"after",
"at",
"least",
"2",
"lines",
"of",
"therapy",
"for",
"multiple",
"myeloma"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT02617589
|
17:29:cancer,33:38:cancer,46:58:cancer,62:65:cancer
|
Newly-diagnosed brain cancer or tumor called glioblastoma or GBM
| 1
|
[
"Newly-diagnosed",
"brain",
"cancer",
"or",
"tumor",
"called",
"glioblastoma",
"or",
"GBM"
] |
[
0,
3,
3,
0,
3,
0,
3,
0,
3
] |
NCT02064036
|
70:94:cancer,
|
Pathologically (histologically or cytologically) proven diagnosis of prostatic adenocarcinoma within 180 days of registration at moderate to high risk for recurrence
| 1
|
[
"Pathologically",
"(",
"histologically",
"or",
"cytologically",
")",
"proven",
"diagnosis",
"of",
"prostatic",
"adenocarcinoma",
"within",
"180",
"days",
"of",
"registration",
"at",
"moderate",
"to",
"high",
"risk",
"for",
"recurrence"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01703117
|
31:62:allergy_name,
|
previously unable to tolerate acetylcholinesterase inhibitors and as a result, are no longer on the medication for at least 2 months
| 1
|
[
"previously",
"unable",
"to",
"tolerate",
"acetylcholinesterase",
"inhibitors",
"and",
"as",
"a",
"result",
",",
"are",
"no",
"longer",
"on",
"the",
"medication",
"for",
"at",
"least",
"2",
"months"
] |
[
0,
0,
0,
0,
4,
4,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01526603
|
40:52:treatment
|
Recovery from last induction course of chemotherapy
| 1
|
[
"Recovery",
"from",
"last",
"induction",
"course",
"of",
"chemotherapy"
] |
[
0,
0,
0,
0,
0,
0,
1
] |
NCT02594111
|
8:18:cancer
|
Active malignancy
| 1
|
[
"Active",
"malignancy"
] |
[
0,
3
] |
NCT02416206
|
19:37:chronic_disease,46:62:chronic_disease,63:78:chronic_disease,89:123:chronic_disease
|
Ongoing or active systemic infection, active hepatitis B or C virus infection, or known human immunodeficiency virus (HIV) positive
| 1
|
[
"Ongoing",
"or",
"active",
"systemic",
"infection",
",",
"active",
"hepatitis",
"B",
"or",
"C",
"virus",
"infection",
",",
"or",
"known",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")",
"positive"
] |
[
0,
0,
0,
2,
2,
0,
0,
2,
2,
2,
2,
2,
2,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0
] |
NCT01903330
|
,86:101:treatment,,131:148:treatment,131:140:treatment,215:244:treatment
|
MRI record must be obtained showing the MRI was conducted at least 4 weeks after any salvage surgery, and at least 12 weeks after radiation therapy, or at least 4 weeks after radiation for a new lesion outside the prior primary radiation field
| 1
|
[
"MRI",
"record",
"must",
"be",
"obtained",
"showing",
"the",
"MRI",
"was",
"conducted",
"at",
"least",
"4",
"weeks",
"after",
"any",
"salvage",
"surgery",
",",
"and",
"at",
"least",
"12",
"weeks",
"after",
"radiation",
"therapy",
",",
"or",
"at",
"least",
"4",
"weeks",
"after",
"radiation",
"for",
"a",
"new",
"lesion",
"outside",
"the",
"prior",
"primary",
"radiation",
"field"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1
] |
NCT02250534
|
6:26:treatment,28:37:treatment,41:64:treatment
|
used nicotine replacement, bupropion or other pharmacotherapies as cessation aids in the past month
| 1
|
[
"used",
"nicotine",
"replacement",
",",
"bupropion",
"or",
"other",
"pharmacotherapies",
"as",
"cessation",
"aids",
"in",
"the",
"past",
"month"
] |
[
0,
1,
1,
0,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT00911560
|
,,178:190:treatment
|
stage 4 with (any age) or without (>18 months old) MYCN amplification, MYCN-amplified stage 3 (unresectable; any age), MYCN-amplified stage 4S, or disease resistant to standard chemotherapy
| 1
|
[
"stage",
"4",
"with",
"(",
"any",
"age",
")",
"or",
"without",
"(",
">",
"18",
"months",
"old",
")",
"MYCN",
"amplification",
",",
"MYCN-amplified",
"stage",
"3",
"(",
"unresectable",
";",
"any",
"age",
")",
",",
"MYCN-amplified",
"stage",
"4S",
",",
"or",
"disease",
"resistant",
"to",
"standard",
"chemotherapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02236000
|
63:78:treatment
|
Conditions that would prohibit intermittent administration of corticosteroids for T-DM1 premedication
| 1
|
[
"Conditions",
"that",
"would",
"prohibit",
"intermittent",
"administration",
"of",
"corticosteroids",
"for",
"T-DM1",
"premedication"
] |
[
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT01880567
|
17:20:cancer,44:56:cancer,,130:140:cancer,142:177:cancer,179:210:cancer,214:220:cancer,268:283:cancer,311:328:treatment,330:337:treatment,341:354:treatment,,
|
Newly diagnosed MCL: Disease free of prior malignancies of equal to or greater than 6 months with exception of currently treated basal cell, squamous cell carcinoma of the skin, carcinoma in situ of the cervix or breast, or other malignancies in remission (including prostate cancer patients in remission from radiation therapy, surgery or brachytherapy), not actively being treated, with a life expectancy > 3 years
| 1
|
[
"Newly",
"diagnosed",
"MCL",
":",
"Disease",
"free",
"of",
"prior",
"malignancies",
"of",
"equal",
"to",
"or",
"greater",
"than",
"6",
"months",
"with",
"exception",
"of",
"currently",
"treated",
"basal",
"cell",
",",
"squamous",
"cell",
"carcinoma",
"of",
"the",
"skin",
",",
"carcinoma",
"in",
"situ",
"of",
"the",
"cervix",
"or",
"breast",
",",
"or",
"other",
"malignancies",
"in",
"remission",
"(",
"including",
"prostate",
"cancer",
"patients",
"in",
"remission",
"from",
"radiation",
"therapy",
",",
"surgery",
"or",
"brachytherapy",
")",
",",
"not",
"actively",
"being",
"treated",
",",
"with",
"a",
"life",
"expectancy",
">",
"3",
"years"
] |
[
0,
0,
3,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
3,
3,
3,
3,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
1,
1,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02081404
|
13:44:chronic_disease
|
Presence of macroscopic erosive esophagitis
| 1
|
[
"Presence",
"of",
"macroscopic",
"erosive",
"esophagitis"
] |
[
0,
0,
2,
2,
2
] |
NCT02166190
|
13:25:chronic_disease
|
Uncorrected coagulopathy
| 1
|
[
"Uncorrected",
"coagulopathy"
] |
[
0,
2
] |
NCT02418195
|
11:31:chronic_disease
|
Cluster A personality disorder
| 1
|
[
"Cluster",
"A",
"personality",
"disorder"
] |
[
0,
0,
2,
2
] |
NCT03042897
|
34:46:treatment
|
Is not a candidate for immediate hysterectomy, following evaluation by a physician, due to desire to preserve fertility, due to degree of obesity, due to comorbidities, or due to patient refusal of hysterectomy
| 1
|
[
"Is",
"not",
"a",
"candidate",
"for",
"immediate",
"hysterectomy",
",",
"following",
"evaluation",
"by",
"a",
"physician",
",",
"due",
"to",
"desire",
"to",
"preserve",
"fertility",
",",
"due",
"to",
"degree",
"of",
"obesity",
",",
"due",
"to",
"comorbidities",
",",
"or",
"due",
"to",
"patient",
"refusal",
"of",
"hysterectomy"
] |
[
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02048852
|
12:34:chronic_disease
|
history of cardiovascular disease
| 1
|
[
"history",
"of",
"cardiovascular",
"disease"
] |
[
0,
0,
2,
2
] |
NCT02321501
|
18:21:chronic_disease
|
Known history of HIV seropositivity
| 1
|
[
"Known",
"history",
"of",
"HIV",
"seropositivity"
] |
[
0,
0,
0,
2,
0
] |
NCT02329652
|
1:4:chronic_disease
|
HIV
| 1
|
[
"HIV"
] |
[
2
] |
NCT02317523
|
1:15:treatment,
|
Glucocorticoid use in the 2 weeks prior to enrollment
| 1
|
[
"Glucocorticoid",
"use",
"in",
"the",
"2",
"weeks",
"prior",
"to",
"enrollment"
] |
[
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02558010
|
1:21:chronic_disease
|
Idiopathic scoliosis
| 1
|
[
"Idiopathic",
"scoliosis"
] |
[
2,
2
] |
NCT02203513
|
,147:159:treatment
|
Patients should have recurrent platinum-resistant, defined as disease recurrence by imaging within 6 months of the last receipt of platinum-based chemotherapy
| 1
|
[
"Patients",
"should",
"have",
"recurrent",
"platinum-resistant",
",",
"defined",
"as",
"disease",
"recurrence",
"by",
"imaging",
"within",
"6",
"months",
"of",
"the",
"last",
"receipt",
"of",
"platinum-based",
"chemotherapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01626079
|
155:170:treatment,207:214:treatment,231:240:treatment
|
The subject or the subject's legal representative understands and agrees that should he/she be assigned to the Control group, he/she will be treated with medical therapy and conservative management without surgery and without the MitraClip, either domestically or abroad
| 1
|
[
"The",
"subject",
"or",
"the",
"subject",
"'s",
"legal",
"representative",
"understands",
"and",
"agrees",
"that",
"should",
"he/she",
"be",
"assigned",
"to",
"the",
"Control",
"group",
",",
"he/she",
"will",
"be",
"treated",
"with",
"medical",
"therapy",
"and",
"conservative",
"management",
"without",
"surgery",
"and",
"without",
"the",
"MitraClip",
",",
"either",
"domestically",
"or",
"abroad"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
1,
0,
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT02539160
|
12:32:treatment,41:48:treatment,53:64:treatment
|
Use of any antiplatelet therapy (except aspirin and clopidogrel)
| 1
|
[
"Use",
"of",
"any",
"antiplatelet",
"therapy",
"(",
"except",
"aspirin",
"and",
"clopidogrel",
")"
] |
[
0,
0,
0,
1,
1,
0,
0,
1,
0,
1,
0
] |
NCT01595529
|
24:33:chronic_disease,,,90:111:treatment,115:123:treatment,
|
A urine culture proven infection with a second uropathogen > 10,000 CFU/mL collected via suprapubic aspiration or catheter or > 50,000 CFU/mL collected via clean void
| 1
|
[
"A",
"urine",
"culture",
"proven",
"infection",
"with",
"a",
"second",
"uropathogen",
">",
"10,000",
"CFU/mL",
"collected",
"via",
"suprapubic",
"aspiration",
"or",
"catheter",
"or",
">",
"50,000",
"CFU/mL",
"collected",
"via",
"clean",
"void"
] |
[
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01037790
|
12:28:chronic_disease
|
ongoing or active infection
| 1
|
[
"ongoing",
"or",
"active",
"infection"
] |
[
0,
0,
2,
2
] |
NCT01754298
|
22:36:treatment
|
History of prolonged corticosteroid
| 1
|
[
"History",
"of",
"prolonged",
"corticosteroid"
] |
[
0,
0,
0,
1
] |
NCT02162420
|
1:15:chronic_disease
|
nail dystrophy
| 1
|
[
"nail",
"dystrophy"
] |
[
2,
2
] |
NCT02525861
|
31:44:treatment,48:69:treatment,79:87:treatment,92:103:treatment,,,266:280:treatment,298:314:treatment
|
If a participant is receiving anticoagulant or anti-platelet therapy (such as warfarin and clopidogrel), the participant is unwilling to or unable to safely discontinue anticoagulant or anti-platelet therapy within 7 days prior to until at least 24 hours after the BAL procedures. An exception is low-dose aspirin alone which is allowed
| 1
|
[
"If",
"a",
"participant",
"is",
"receiving",
"anticoagulant",
"or",
"anti-platelet",
"therapy",
"(",
"such",
"as",
"warfarin",
"and",
"clopidogrel",
")",
",",
"the",
"participant",
"is",
"unwilling",
"to",
"or",
"unable",
"to",
"safely",
"discontinue",
"anticoagulant",
"or",
"anti-platelet",
"therapy",
"within",
"7",
"days",
"prior",
"to",
"until",
"at",
"least",
"24",
"hours",
"after",
"the",
"BAL",
"procedures",
".",
"An",
"exception",
"is",
"low-dose",
"aspirin",
"alone",
"which",
"is",
"allowed"
] |
[
0,
0,
0,
0,
0,
1,
0,
1,
1,
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0
] |
NCT02435992
|
14:16:chronic_disease,18:39:chronic_disease,60:67:chronic_disease,90:109:chronic_disease,111:128:chronic_disease,133:149:chronic_disease
|
Diagnosis of CD, indeterminate colitis, or the presence of fistula consistent with CD or microscopic colitis, radiation colitis, or ischemic colitis
| 1
|
[
"Diagnosis",
"of",
"CD",
",",
"indeterminate",
"colitis",
",",
"or",
"the",
"presence",
"of",
"fistula",
"consistent",
"with",
"CD",
"or",
"microscopic",
"colitis",
",",
"radiation",
"colitis",
",",
"or",
"ischemic",
"colitis"
] |
[
0,
0,
2,
0,
2,
2,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
2,
2,
0,
2,
2,
0,
0,
2,
2
] |
NCT02442297
|
,124:139:treatment
|
Sexually active subjects must be willing to utilize one of the more effective birth control methods for 6 months after the T cell infusion
| 1
|
[
"Sexually",
"active",
"subjects",
"must",
"be",
"willing",
"to",
"utilize",
"one",
"of",
"the",
"more",
"effective",
"birth",
"control",
"methods",
"for",
"6",
"months",
"after",
"the",
"T",
"cell",
"infusion"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT02171104
|
1:23:chronic_disease
|
Aspartylglucosaminuria
| 1
|
[
"Aspartylglucosaminuria"
] |
[
2
] |
NCT02091999
|
1:13:treatment
|
chemotherapy
| 1
|
[
"chemotherapy"
] |
[
1
] |
NCT02020707
|
24:51:chronic_disease
|
Clinically significant peripheral vascular disease
| 1
|
[
"Clinically",
"significant",
"peripheral",
"vascular",
"disease"
] |
[
0,
0,
2,
2,
2
] |
NCT02815670
|
36:43:treatment,47:65:treatment,81:92:treatment
|
A condition requiring an emergency surgery or invasive procedure where adequate haemostasis
| 1
|
[
"A",
"condition",
"requiring",
"an",
"emergency",
"surgery",
"or",
"invasive",
"procedure",
"where",
"adequate",
"haemostasis"
] |
[
0,
0,
0,
0,
0,
1,
0,
1,
1,
0,
0,
1
] |
NCT02519322
|
,,,51:60:treatment
|
Lipase < 1.5 X ULN (within 28 days of first study treatment)
| 1
|
[
"Lipase",
"<",
"1.5",
"X",
"ULN",
"(",
"within",
"28",
"days",
"of",
"first",
"study",
"treatment",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02347202
|
71:79:chronic_disease
|
caregivers who participate must be spouses or partners of people with dementia living with them at home when they enter the study
| 1
|
[
"caregivers",
"who",
"participate",
"must",
"be",
"spouses",
"or",
"partners",
"of",
"people",
"with",
"dementia",
"living",
"with",
"them",
"at",
"home",
"when",
"they",
"enter",
"the",
"study"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01919619
|
13:23:chronic_disease,,
|
Significant neuropathy (grades 3 to 4 or grade 2 pain)
| 1
|
[
"Significant",
"neuropathy",
"(",
"grades",
"3",
"to",
"4",
"or",
"grade",
"2",
"pain",
")"
] |
[
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02146924
|
53:63:cancer
|
Research participants with presence of other active malignancy
| 1
|
[
"Research",
"participants",
"with",
"presence",
"of",
"other",
"active",
"malignancy"
] |
[
0,
0,
0,
0,
0,
0,
0,
3
] |
NCT01042522
|
5:21:treatment,38:53:cancer,,132:159:treatment
|
Any hormonal therapy directed at the malignant tumor must be discontinued at least one week prior to registration; continuation of hormone replacement therapy is permitted
| 1
|
[
"Any",
"hormonal",
"therapy",
"directed",
"at",
"the",
"malignant",
"tumor",
"must",
"be",
"discontinued",
"at",
"least",
"one",
"week",
"prior",
"to",
"registration",
";",
"continuation",
"of",
"hormone",
"replacement",
"therapy",
"is",
"permitted"
] |
[
0,
1,
1,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0
] |
NCT02460900
|
20:28:chronic_disease,,
|
Meets criteria for dementia by scoring below 10 on the Hopkins HIV Dementia Scale
| 1
|
[
"Meets",
"criteria",
"for",
"dementia",
"by",
"scoring",
"below",
"10",
"on",
"the",
"Hopkins",
"HIV",
"Dementia",
"Scale"
] |
[
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03123068
|
8:18:cancer
|
Active malignancy
| 1
|
[
"Active",
"malignancy"
] |
[
0,
3
] |
NCT02911831
|
21:34:chronic_disease,,,
|
Patients with known renal failure and/or Cr > 5 within the last 6 months
| 1
|
[
"Patients",
"with",
"known",
"renal",
"failure",
"and/or",
"Cr",
">",
"5",
"within",
"the",
"last",
"6",
"months"
] |
[
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02905591
|
11:37:cancer
|
Recurrent non-small cell lung cancer
| 1
|
[
"Recurrent",
"non-small",
"cell",
"lung",
"cancer"
] |
[
0,
3,
3,
3,
3
] |
NCT00107289
|
52:64:treatment
|
Three weeks should have elapsed since last dose of chemotherapy
| 1
|
[
"Three",
"weeks",
"should",
"have",
"elapsed",
"since",
"last",
"dose",
"of",
"chemotherapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02784535
|
1:24:chronic_disease,,
|
Impaired renal function (serum creatinine equal or more than 1.6 mg/dl)
| 1
|
[
"Impaired",
"renal",
"function",
"(",
"serum",
"creatinine",
"equal",
"or",
"more",
"than",
"1.6",
"mg/dl",
")"
] |
[
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02417701
|
42:62:treatment,58:61:treatment,117:128:treatment,,209:220:treatment
|
Concomitant administration of any proton pump inhibitor (PPI) is not permitted during the study; patients receiving PPI therapy before enrollment must stop using the PPI for 7 days before their first dose of study drugs
| 1
|
[
"Concomitant",
"administration",
"of",
"any",
"proton",
"pump",
"inhibitor",
"(",
"PPI",
")",
"is",
"not",
"permitted",
"during",
"the",
"study",
";",
"patients",
"receiving",
"PPI",
"therapy",
"before",
"enrollment",
"must",
"stop",
"using",
"the",
"PPI",
"for",
"7",
"days",
"before",
"their",
"first",
"dose",
"of",
"study",
"drugs"
] |
[
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02916524
|
,41:63:chronic_disease
|
At least 6 months post-onset of single, left-hemisphere stroke
| 1
|
[
"At",
"least",
"6",
"months",
"post-onset",
"of",
"single",
",",
"left-hemisphere",
"stroke"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT02106650
|
,,,,,,,,283:291:cancer
|
Aspartate aminotransferase/serum glutamic-oxaloacetic transaminase (AST/SGOT), alanine aminotransferase/serum glutamic-pyruvic transaminase (ALT/SGPT), and gamma-glutamyltransferase (GGT) ≤2.5 xupper limit of normal (ULN) (AST/ALT/GGT ≤5 xULN if documented hepatic involvement with lymphoma)
| 1
|
[
"Aspartate",
"aminotransferase/serum",
"glutamic-oxaloacetic",
"transaminase",
"(",
"AST/SGOT",
")",
",",
"alanine",
"aminotransferase/serum",
"glutamic-pyruvic",
"transaminase",
"(",
"ALT/SGPT",
")",
",",
"and",
"gamma-glutamyltransferase",
"(",
"GGT",
")",
"≤2.5",
"xupper",
"limit",
"of",
"normal",
"(",
"ULN",
")",
"(",
"AST/ALT/GGT",
"≤5",
"xULN",
"if",
"documented",
"hepatic",
"involvement",
"with",
"lymphoma",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0
] |
NCT02660528
|
1:6:chronic_disease
|
mania
| 1
|
[
"mania"
] |
[
2
] |
NCT01570998
|
1:20:cancer
|
Multicentric cancer in the same breast as diagnosed by clinical examination
| 1
|
[
"Multicentric",
"cancer",
"in",
"the",
"same",
"breast",
"as",
"diagnosed",
"by",
"clinical",
"examination"
] |
[
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02573883
|
35:57:cancer
|
Current or prior diagnosis of any gynecologic malignancy
| 1
|
[
"Current",
"or",
"prior",
"diagnosis",
"of",
"any",
"gynecologic",
"malignancy"
] |
[
0,
0,
0,
0,
0,
0,
3,
3
] |
NCT01760655
|
1:4:chronic_disease
|
HIV positive
| 1
|
[
"HIV",
"positive"
] |
[
2,
0
] |
NCT01811368
|
1:10:chronic_disease,28:47:chronic_disease,51:68:chronic_disease
|
Cirrhosis with evidence of portal hypertension or bridging fibrosis
| 1
|
[
"Cirrhosis",
"with",
"evidence",
"of",
"portal",
"hypertension",
"or",
"bridging",
"fibrosis"
] |
[
2,
0,
0,
0,
2,
2,
0,
2,
2
] |
NCT02515110
|
8:33:chronic_disease,48:63:chronic_disease,,137:146:chronic_disease,148:176:chronic_disease,181:192:chronic_disease
|
Active collagen vascular disease, specifically dermatomyositis with a creatine phosphokinase (CPK) level above normal or with an active skin rash, systemic lupus erythematosus, or scleroderma
| 1
|
[
"Active",
"collagen",
"vascular",
"disease",
",",
"specifically",
"dermatomyositis",
"with",
"a",
"creatine",
"phosphokinase",
"(",
"CPK",
")",
"level",
"above",
"normal",
"or",
"with",
"an",
"active",
"skin",
"rash",
",",
"systemic",
"lupus",
"erythematosus",
",",
"or",
"scleroderma"
] |
[
0,
2,
2,
2,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
2,
2,
0,
0,
2
] |
NCT01504373
|
1:34:chronic_disease
|
Congenital cyanotic heart defects
| 1
|
[
"Congenital",
"cyanotic",
"heart",
"defects"
] |
[
2,
2,
2,
2
] |
NCT02064296
|
45:67:treatment
|
Able to travel to the study site to receive acupuncture treatments up to two times weekly
| 1
|
[
"Able",
"to",
"travel",
"to",
"the",
"study",
"site",
"to",
"receive",
"acupuncture",
"treatments",
"up",
"to",
"two",
"times",
"weekly"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT02496208
|
,91:100:treatment
|
Any of the following that have not resolved within 28 days before the first dose of study treatment
| 1
|
[
"Any",
"of",
"the",
"following",
"that",
"have",
"not",
"resolved",
"within",
"28",
"days",
"before",
"the",
"first",
"dose",
"of",
"study",
"treatment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02532621
|
,59:68:treatment
|
The patient has had >2 previous arteriovenous accesses in treatment arm
| 1
|
[
"The",
"patient",
"has",
"had",
">",
"2",
"previous",
"arteriovenous",
"accesses",
"in",
"treatment",
"arm"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT03123068
|
12:42:allergy_name
|
Allergy to active ingredient of CocoaVia®, the study intervention
| 1
|
[
"Allergy",
"to",
"active",
"ingredient",
"of",
"CocoaVia®",
",",
"the",
"study",
"intervention"
] |
[
0,
0,
4,
4,
4,
4,
0,
0,
0,
0
] |
NCT01608438
|
1:16:chronic_disease,18:32:chronic_disease,36:46:chronic_disease,
|
Skull fractures, skull deficits or concussion within the last 6 months
| 1
|
[
"Skull",
"fractures",
",",
"skull",
"deficits",
"or",
"concussion",
"within",
"the",
"last",
"6",
"months"
] |
[
2,
2,
0,
2,
2,
0,
2,
0,
0,
0,
0,
0
] |
NCT02370056
|
1:27:treatment
|
Segmental colon resections
| 1
|
[
"Segmental",
"colon",
"resections"
] |
[
1,
1,
1
] |
NCT02159495
|
19:22:cancer,37:61:cancer,,112:134:treatment
|
for patients with AML evolving from myelodysplastic syndrome, they should have completed at least one cycle of induction chemotherapy
| 1
|
[
"for",
"patients",
"with",
"AML",
"evolving",
"from",
"myelodysplastic",
"syndrome",
",",
"they",
"should",
"have",
"completed",
"at",
"least",
"one",
"cycle",
"of",
"induction",
"chemotherapy"
] |
[
0,
0,
0,
3,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT03089515
|
,,60:71:treatment,
|
Using ICS/LABA (Advair HFA equivalent > 115/21 mcg bid) or Fluticasone (110 mcg bid or equivalent) for at least 1 month before Study Visit 1
| 1
|
[
"Using",
"ICS/LABA",
"(",
"Advair",
"HFA",
"equivalent",
">",
"115/21",
"mcg",
"bid",
")",
"or",
"Fluticasone",
"(",
"110",
"mcg",
"bid",
"or",
"equivalent",
")",
"for",
"at",
"least",
"1",
"month",
"before",
"Study",
"Visit",
"1"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02576444
|
41:59:treatment
|
Patients with concomitant use of drugs, herbal supplements and/or ingestion of foods known to strongly modulate CYP3A4 enzyme activity as specified in the drug specific appendix
| 1
|
[
"Patients",
"with",
"concomitant",
"use",
"of",
"drugs",
",",
"herbal",
"supplements",
"and/or",
"ingestion",
"of",
"foods",
"known",
"to",
"strongly",
"modulate",
"CYP3A4",
"enzyme",
"activity",
"as",
"specified",
"in",
"the",
"drug",
"specific",
"appendix"
] |
[
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02866279
|
1:28:chronic_disease
|
Polycystic Ovarian Syndrome
| 1
|
[
"Polycystic",
"Ovarian",
"Syndrome"
] |
[
2,
2,
2
] |
NCT02422641
|
1:27:treatment,,,
|
Partial brain radiotherapy (i.e., less than or equal to 40% of total brain volume) within the last two weeks
| 1
|
[
"Partial",
"brain",
"radiotherapy",
"(",
"i.e.",
",",
"less",
"than",
"or",
"equal",
"to",
"40",
"%",
"of",
"total",
"brain",
"volume",
")",
"within",
"the",
"last",
"two",
"weeks"
] |
[
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03101566
|
30:53:chronic_disease
|
Must have no ongoing active, uncontrolled infections
| 1
|
[
"Must",
"have",
"no",
"ongoing",
"active",
",",
"uncontrolled",
"infections"
] |
[
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT01415882
|
1:11:treatment,18:27:treatment,29:45:treatment,
|
Alkylators (e.g. melphalan, cyclophosphamide) =< 14 days prior to registration
| 1
|
[
"Alkylators",
"(",
"e.g",
".",
"melphalan",
",",
"cyclophosphamide",
")",
"=",
"<",
"14",
"days",
"prior",
"to",
"registration"
] |
[
1,
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01539109
|
1:12:cancer
|
Brain tumor
| 1
|
[
"Brain",
"tumor"
] |
[
3,
3
] |
NCT03129542
|
1:9:chronic_disease
|
glaucoma
| 1
|
[
"glaucoma"
] |
[
2
] |
NCT02440581
|
1:19:chronic_disease,23:37:chronic_disease,67:101:chronic_disease
|
Systemic illnesses or organ diseases that may affect bone (except type 1 or type 2 diabetes mellitus)
| 1
|
[
"Systemic",
"illnesses",
"or",
"organ",
"diseases",
"that",
"may",
"affect",
"bone",
"(",
"except",
"type",
"1",
"or",
"type",
"2",
"diabetes",
"mellitus",
")"
] |
[
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
2,
2,
2,
2,
2,
2,
2,
0
] |
NCT02008656
|
36:46:cancer,
|
Patients with a history of a prior malignancy within the past 5 years
| 1
|
[
"Patients",
"with",
"a",
"history",
"of",
"a",
"prior",
"malignancy",
"within",
"the",
"past",
"5",
"years"
] |
[
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0
] |
NCT01526603
|
43:55:treatment,
|
Patients who are delayed in consolidation chemotherapy beyond 8 weeks
| 1
|
[
"Patients",
"who",
"are",
"delayed",
"in",
"consolidation",
"chemotherapy",
"beyond",
"8",
"weeks"
] |
[
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT02830074
|
64:72:chronic_disease
|
unable to provide self-consent for participation (e.g., due to dementia)
| 1
|
[
"unable",
"to",
"provide",
"self-consent",
"for",
"participation",
"(",
"e.g.",
",",
"due",
"to",
"dementia",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0
] |
NCT01923662
|
12:34:chronic_disease
|
History of vestibular dysfunction, balance problems or spontaneous falls
| 1
|
[
"History",
"of",
"vestibular",
"dysfunction",
",",
"balance",
"problems",
"or",
"spontaneous",
"falls"
] |
[
0,
0,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02143726
|
41:68:cancer
|
must have histopathologically confirmed Hürthle cell thyroid cancer by central review
| 1
|
[
"must",
"have",
"histopathologically",
"confirmed",
"Hürthle",
"cell",
"thyroid",
"cancer",
"by",
"central",
"review"
] |
[
0,
0,
0,
0,
3,
3,
3,
3,
0,
0,
0
] |
NCT01898793
|
27:36:chronic_disease,,91:98:treatment,131:148:chronic_disease
|
Infiltrates attributed to infection must be stable/ improving after 1 week of appropriate therapy (4 weeks for presumed or proven fungal infections)
| 1
|
[
"Infiltrates",
"attributed",
"to",
"infection",
"must",
"be",
"stable/",
"improving",
"after",
"1",
"week",
"of",
"appropriate",
"therapy",
"(",
"4",
"weeks",
"for",
"presumed",
"or",
"proven",
"fungal",
"infections",
")"
] |
[
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0
] |
NCT02465060
|
10:17:treatment
|
Low dose steroid use for appetite
| 1
|
[
"Low",
"dose",
"steroid",
"use",
"for",
"appetite"
] |
[
0,
0,
1,
0,
0,
0
] |
NCT01928589
|
28:52:treatment,56:84:treatment,101:107:cancer
|
Patients who have received neoadjuvant chemotherapy or neoadjuvant hormonal therapy for the current cancer
| 1
|
[
"Patients",
"who",
"have",
"received",
"neoadjuvant",
"chemotherapy",
"or",
"neoadjuvant",
"hormonal",
"therapy",
"for",
"the",
"current",
"cancer"
] |
[
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
3
] |
NCT02122185
|
71:95:cancer,113:130:chronic_disease,134:141:chronic_disease
|
they should have presumed stage III or IV disease, generally based on abdominal carcinomatosis, omental caking, pleural effusions or ascites
| 1
|
[
"they",
"should",
"have",
"presumed",
"stage",
"III",
"or",
"IV",
"disease",
",",
"generally",
"based",
"on",
"abdominal",
"carcinomatosis",
",",
"omental",
"caking",
",",
"pleural",
"effusions",
"or",
"ascites"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
2,
2,
0,
2
] |
NCT03104699
|
20:34:treatment,38:47:treatment,75:84:treatment,,129:137:treatment
|
Subjects receiving bisphosphonate or denosumab are eligible provided that treatment was initiated ≥14 days before first dose of AGEN2034
| 1
|
[
"Subjects",
"receiving",
"bisphosphonate",
"or",
"denosumab",
"are",
"eligible",
"provided",
"that",
"treatment",
"was",
"initiated",
"≥14",
"days",
"before",
"first",
"dose",
"of",
"AGEN2034"
] |
[
0,
0,
1,
0,
1,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02734771
|
17:30:treatment,35:40:cancer,44:46:chronic_disease,81:91:treatment,,134:142:cancer,179:198:cancer,219:257:treatment
|
Has received no prior therapy for DLBCL or HT with the exception of a course of prednisone of less than or equal to 7 days given for lymphoma related symptoms; prior therapy for follicular lymphoma is accepted, but no prior anthracycline-containing therapy
| 1
|
[
"Has",
"received",
"no",
"prior",
"therapy",
"for",
"DLBCL",
"or",
"HT",
"with",
"the",
"exception",
"of",
"a",
"course",
"of",
"prednisone",
"of",
"less",
"than",
"or",
"equal",
"to",
"7",
"days",
"given",
"for",
"lymphoma",
"related",
"symptoms",
";",
"prior",
"therapy",
"for",
"follicular",
"lymphoma",
"is",
"accepted",
",",
"but",
"no",
"prior",
"anthracycline-containing",
"therapy"
] |
[
0,
0,
0,
1,
1,
1,
3,
0,
2,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02565901
|
10:20:cancer
|
No prior malignancy
| 1
|
[
"No",
"prior",
"malignancy"
] |
[
0,
0,
3
] |
NCT03060473
|
8:32:chronic_disease,,
|
Active congestive heart failure (EF<45%)
| 1
|
[
"Active",
"congestive",
"heart",
"failure",
"(",
"EF",
"<",
"45",
"%",
")"
] |
[
0,
2,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02128906
|
,,53:65:treatment
|
Pregnant women are excluded from this study because chemotherapy
| 1
|
[
"Pregnant",
"women",
"are",
"excluded",
"from",
"this",
"study",
"because",
"chemotherapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT03096886
|
21:45:treatment
|
Willing to not take psychotropic medications for the duration of the study
| 1
|
[
"Willing",
"to",
"not",
"take",
"psychotropic",
"medications",
"for",
"the",
"duration",
"of",
"the",
"study"
] |
[
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02845596
|
24:38:chronic_disease
|
Confirmed diagnosis of idiopathic SAA
| 1
|
[
"Confirmed",
"diagnosis",
"of",
"idiopathic",
"SAA"
] |
[
0,
0,
0,
2,
2
] |
NCT02520713
|
25:41:cancer
|
Histologic diagnosis of solid malignancy
| 1
|
[
"Histologic",
"diagnosis",
"of",
"solid",
"malignancy"
] |
[
0,
0,
0,
3,
3
] |
NCT02483910
|
69:78:treatment,
|
Stable educational plan with no planned changes in the intensity of treatment for 6 months
| 1
|
[
"Stable",
"educational",
"plan",
"with",
"no",
"planned",
"changes",
"in",
"the",
"intensity",
"of",
"treatment",
"for",
"6",
"months"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT02159027
|
15:32:chronic_disease
|
other serious medical illnesses (in the opinion of the site investigator)
| 1
|
[
"other",
"serious",
"medical",
"illnesses",
"(",
"in",
"the",
"opinion",
"of",
"the",
"site",
"investigator",
")"
] |
[
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02759120
|
38:55:chronic_disease
|
If the enrolling physician feels the renal dysfunction has resolved, documentation to that effect must be provided
| 1
|
[
"If",
"the",
"enrolling",
"physician",
"feels",
"the",
"renal",
"dysfunction",
"has",
"resolved",
",",
"documentation",
"to",
"that",
"effect",
"must",
"be",
"provided"
] |
[
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02245841
|
15:52:cancer
|
Patients with malignancy-associated dermatomyositis
| 1
|
[
"Patients",
"with",
"malignancy-associated",
"dermatomyositis"
] |
[
0,
0,
3,
3
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.